XBP1 and neoplasm: Earlier reports showed that XBP1 is required for the development and survival of BMDC [44] and that the deletion of XBP1 in lymphoid dendritic cells [40,45] or in tumor-associated dendritic cells [36] improves antigen cross-priming and reduces tumor (ovarian) growth in the mouse.